India, Oct. 14 -- Johnson & Johnson has paused the trial of its vaccine candidate for the coronavirus after an unexplained illness in one of the participants, although it wasn't immediately clear whether the person was part of the test (or experimental group) which receives the shot, or the control group which doesn't (people in this group usually receive a placebo)....